Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18957782 | METHOD AND SYSTEMS FOR GENERATING AN ENTITY DURATION VALUE WITHIN A GRAPHICAL USER INTERFACE | November 2024 | October 2025 | Allow | 11 | 3 | 0 | Yes | No |
| 18674971 | SYSTEMS AND METHODS FOR DEVICE CONTROL | May 2024 | February 2026 | Allow | 21 | 1 | 0 | No | No |
| 18674222 | Care Provider Coverage Filter for Communication Devices | May 2024 | February 2026 | Allow | 21 | 1 | 0 | No | No |
| 18444278 | TELEMEDICINE PLATFORM INCLUDING VIRTUAL ASSISTANCE | February 2024 | April 2025 | Allow | 14 | 1 | 0 | No | No |
| 18429058 | Determining A Cardiovascular Ischemic Event And Decision Support Tool | January 2024 | October 2024 | Allow | 9 | 1 | 0 | No | No |
| 18520063 | Salubrity Retention System Using Selective Digital Communications | November 2023 | March 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18339726 | METHODS FOR EVALUATING THE EFFECT OF THE START DATE FOR CANCER TREATMENT WITH A CANCER MEDICATION USING PROPENSITY SCORING | June 2023 | July 2025 | Allow | 25 | 4 | 0 | Yes | No |
| 18337373 | Systems, Methods and Apparatus of a Virtual Medical Masterclass | June 2023 | January 2025 | Abandon | 19 | 4 | 0 | No | No |
| 18332798 | DIGITAL MEDICAL IMAGE TEACHING AND RESEARCH SYSTEM | June 2023 | September 2025 | Abandon | 28 | 1 | 0 | No | No |
| 18032297 | CARDIOVASCULAR DISEASE RISK ASSESSMENT SYSTEMS AND USES THEREOF | April 2023 | December 2025 | Abandon | 32 | 2 | 0 | No | No |
| 18031166 | PATIENT MONITORING SYSTEM | April 2023 | January 2026 | Abandon | 33 | 3 | 0 | No | No |
| 18246892 | A Neural Graph Model for Automated Clinical Assessment Generation | March 2023 | January 2026 | Abandon | 34 | 2 | 0 | No | No |
| 18157289 | AI-BASED APPLICATION TO PREDICT APPOINTMENT ADHERENCE IN PEDIATRIC SETTINGS | January 2023 | May 2025 | Abandon | 28 | 1 | 0 | No | No |
| 18146735 | APPARATUS, METHOD AND COMPUTER READABLE STORAGE MEDIUM FOR PREDICTING BLOOD PRESSURE NON-COMPRESSIVELY USING CONVOLUTIONAL NEURAL NETWORK AND LONG-SHORT-TERM MEMORY NETWORK | December 2022 | January 2026 | Abandon | 36 | 2 | 0 | No | No |
| 18007541 | METHODS AND SYSTEMS FOR SEARCHING AN ECG DATABASE | December 2022 | April 2025 | Abandon | 29 | 1 | 0 | No | No |
| 17991079 | METHODS, SYSTEMS, AND DEVICES FOR DETERMINING MUTLI-PARTY COLOCATION | November 2022 | March 2025 | Allow | 28 | 1 | 0 | Yes | No |
| 17924102 | METHOD FOR CONTROLLED AND TRUST-AWARE CONTACT TRACING WITH ACTIVE INVOLVEMENT OF CONTACT ACTORS | November 2022 | December 2025 | Abandon | 37 | 2 | 0 | No | No |
| 17997584 | DATA PROVENANCE, LOCALIZATION, AND ANALYSIS FOR PERSONAL DATA COLLECTED IN A PRIVATE ENTERPRISE NETWORK | October 2022 | April 2025 | Abandon | 29 | 1 | 0 | No | No |
| 18048460 | ROBOT CONTROL METHOD AND INFORMATION PROVIDING METHOD | October 2022 | February 2025 | Abandon | 28 | 3 | 0 | Yes | No |
| 17939921 | System and Method for More Accurate Estimation of Vaccine Efficacy by Taking Into Account the Rate of Herd Immunity | September 2022 | December 2025 | Abandon | 39 | 2 | 0 | No | Yes |
| 17904407 | SYSTEM AND METHOD FOR PROVIDING FERTILITY ENHANCING DIETARY RECOMMENDATIONS IN INDIVIDUALS WITH ENDOMETRIOSIS | August 2022 | January 2025 | Abandon | 29 | 1 | 0 | Yes | No |
| 17812822 | PLANNING SYSTEM BASED ON RISKS OF SURGICAL ERROR | July 2022 | July 2025 | Abandon | 36 | 2 | 0 | No | No |
| 17791219 | A REMOTE MEDICAL EXAMINATION SYSTEM AND METHOD | July 2022 | January 2025 | Abandon | 31 | 1 | 0 | No | No |
| 17704492 | Systems and Methods for Prediction and Estimation of Medical Claims Payments | March 2022 | March 2026 | Allow | 47 | 4 | 0 | Yes | No |
| 17639939 | A COMPUTER-IMPLEMENTED SYSTEM AND METHOD FOR ALERTING AN EXPECTANT MOTHER TO A MEDICAL RISK DURING PREGNANCY | March 2022 | March 2026 | Abandon | 48 | 2 | 0 | Yes | Yes |
| 17573259 | CLINICAL DRUG TRIAL DATA ENRICHING USING ACTIVITY AND BEHAVIORAL ANALYTICS CAPTURED WITH PERSONAL DEVICES AND APPS | January 2022 | October 2025 | Abandon | 46 | 1 | 0 | No | No |
| 17449229 | INCORPORATING CLINICAL AND ECONOMIC OBJECTIVES FOR MEDICAL AI DEPLOYMENT IN CLINICAL DECISION MAKING | September 2021 | January 2026 | Allow | 52 | 5 | 0 | Yes | No |
| 17484320 | SYSTEM FOR PATIENT REGISTRATION, CHECK-IN, AND SERVICE | September 2021 | December 2024 | Allow | 38 | 2 | 0 | Yes | No |
| 17384508 | HUB IDENTIFICATION AND TRACKING OF OBJECTS AND PERSONNEL WITHIN THE OR TO OVERLAY DATA THAT IS CUSTOM TO THE USER'S NEED | July 2021 | May 2025 | Abandon | 45 | 4 | 0 | No | No |
| 17424564 | METHOD FOR DETERMINING A MODEL OF AN EXTREMITY, COMPUTER-READABLE STORAGE MEDIUM AND SYSTEM | July 2021 | January 2025 | Allow | 42 | 3 | 0 | Yes | No |
| 17424315 | MEDICAL IMAGE RECONSTRUCTION AND TRANSMISSION SYSTEM AND METHOD | July 2021 | March 2026 | Allow | 56 | 5 | 0 | No | No |
| 17422352 | STABILITY ESTIMATION OF A POINT SET REGISTRATION | July 2021 | October 2025 | Allow | 51 | 5 | 0 | Yes | No |
| 17421513 | CARE RECORDING DEVICE, CARE RECORDING SYSTEM, CARE RECORDING PROGRAM, AND CARE RECORDING METHOD | July 2021 | May 2025 | Abandon | 46 | 4 | 0 | No | No |
| 17416376 | ARTIFICIAL INTELLIGENCE PROCESSING SYSTEM AND AUTOMATED PRE-DIAGNOSTIC WORKFLOW FOR DIGITAL PATHOLOGY | June 2021 | August 2025 | Abandon | 50 | 4 | 0 | Yes | No |
| 17335420 | AGGREGATED NETWORK OF SURGICAL HUBS FOR EFFICIENCY ANALYSIS | June 2021 | January 2026 | Allow | 55 | 5 | 0 | Yes | No |
| 17330813 | System and Method for Virtual Verification in Pharmacy Workflow | May 2021 | September 2025 | Allow | 52 | 5 | 0 | Yes | No |
| 17279915 | AUTOMATIC SETTING OF IMAGING PARAMETERS | March 2021 | November 2025 | Allow | 56 | 5 | 0 | Yes | No |
| 17264856 | AN OPERATING ROOM CONTROL SYSTEM, METHOD, AND PROGRAM | February 2021 | May 2025 | Abandon | 51 | 4 | 0 | Yes | No |
| 17148376 | SYSTEMS AND METHODS FOR AN ADAPTIVE INTERFACE FOR AN ULTRASOUND IMAGING SYSTEM | January 2021 | July 2024 | Allow | 42 | 3 | 0 | Yes | No |
| 17132463 | MEDICAL INFORMATION PROCESSING SYSTEM, MEDICAL INFORMATION PROCESSING APPARATUS, AND MEDICAL INFORMATION PROCESSING METHOD | December 2020 | May 2025 | Abandon | 52 | 5 | 0 | No | No |
| 17053975 | GENERATING A 3D-PRINTED MEDICAL APPLIANCE TREATMENT PLAN AND PROVIDING 3D-PRINTED MEDICAL APPLIANCES IN ACCORDANCE THEREWITH | November 2020 | March 2025 | Allow | 52 | 2 | 0 | Yes | Yes |
| 17062519 | RECONFIGURATION OF DISPLAY SHARING | October 2020 | November 2025 | Abandon | 60 | 6 | 0 | No | No |
| 16980386 | INTELLIGENT SCHEDULER FOR CENTRALIZED CONTROL OF IMAGING EXAMINATIONS | September 2020 | June 2025 | Abandon | 57 | 4 | 0 | No | Yes |
| 16923297 | SIMULATION-ENHANCED INTRAOPERATIVE SURGICAL PLANNING TOOL FOR ROBOTICS-ASSISTED TOTAL KNEE ARTHROPLASTY | July 2020 | June 2024 | Allow | 47 | 4 | 0 | Yes | No |
| 16756588 | FUNCTIONAL BIOMARKERS FOR STATIN THERAPY IN AGE-RELATED MACULAR DEGENERATION (AMD) | April 2020 | March 2026 | Allow | 60 | 7 | 0 | Yes | No |
| 16777792 | CLINICAL TRIAL OVERSIGHT AND IDENTIFICATION OF ERRORS IN CLINICAL TRIAL PROCEDURE | January 2020 | November 2024 | Abandon | 57 | 2 | 0 | Yes | Yes |
| 16237659 | MULTI-FACTOR CONTROL SYSTEM FOR OPHTHALMIC REFRACTION MODIFICATION | December 2018 | September 2025 | Abandon | 60 | 6 | 0 | No | No |
| 16145461 | METHODS AND SYSTEMS FOR RADIOTHERAPY TREATMENT PLANNING USING DEEP LEARNING ENGINES | September 2018 | June 2024 | Allow | 60 | 5 | 0 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ERICKSON, BENNETT S.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner ERICKSON, BENNETT S works in Art Unit 3683 and has examined 22 patent applications in our dataset. With an allowance rate of 59.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 52 months.
Examiner ERICKSON, BENNETT S's allowance rate of 59.1% places them in the 19% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by ERICKSON, BENNETT S receive 4.32 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ERICKSON, BENNETT S is 52 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +65.7% benefit to allowance rate for applications examined by ERICKSON, BENNETT S. This interview benefit is in the 98% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 20.0% of applications are subsequently allowed. This success rate is in the 21% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 76% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 20% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.